z-logo
open-access-imgOpen Access
Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy
Author(s) -
Xiaogang Zhong,
Bin Wei,
Zhenyu Zhang
Publication year - 2015
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s78461
Subject(s) - gene knockdown , cell cycle , gene silencing , cancer research , viability assay , flow cytometry , downregulation and upregulation , apoptosis , small interfering rna , cell cycle checkpoint , transfection , cell growth , colorectal cancer , g1 phase , metastasis , biology , medicine , cell culture , cancer , microbiology and biotechnology , gene , biochemistry , genetics
Nucleostemin (NS) is a new protein localized in the nucleolus of most stem cells and tumor cells, which regulates their self-renewal and cell cycle progression. The aim of this study was to investigate the expression of NS in colorectal cancer (CRC) and the effects of NS knockdown in the Sw620 cell line to provide basis for clinical target therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom